Mesothelioma: Pleural, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · NCCN · 08/17/2026
Authors: Stevenson, James; Riely, Gregory J; Wood, Douglas E; Aisner, Dara L; Axtell, Andrea L; Bauman, Jessica R; Bharat, Ankit; Chang, Joe Y; Desai, Aakash; Dilling, Thomas J; Dowell, Jonathan; Durm, Gregory A; Gettinger, Scott; Grotz, Travis E; Gubens, Matthew A; Juloori, Aditya; Lackner, Rudy P; Lanuti, Michael; Levy, Benjamin; Lin, Jules
Publication types: Journal Article, Practice Guideline
PubMed abstract / permitted excerpt
Mesothelioma is a rare cancer that originates from the mesothelial surfaces of certain sites within the body. Pleural mesothelioma is the most common type and represents approximately 85% of mesotheliomas. The NCCN Guidelines for Mesothelioma: Pleural provide recommendations for evaluation and treatment in patients with pleural mesothelioma. The NCCN Guidelines will continue to be updated annually based on available clinical evidence and panel consensus.
Full-text bodies are not stored. JNCCN via PubMed only. NCCN guideline recommendation text is never stored or shown. UI links to official NCCN hubs.